Collage Photo of Nicholas Short and
Fadi Haddad
Sep 25, 2024, 14:36
Fadi Haddad: DAC-VEN-PONATINIB in CML MBP by Nicholas Short
Fadi Haddad posted on X:
“Out in The Lancet Haematology
DAC-VEN-PONATINIB in CML MBP by Nicholas Short
N=20, median age 43
60% had >=2 prior TKI
CR/CRi=50%, 8 had transplant
G3-4 AEs mostly Infectious or transaminitis
2-y RFS=37%, 2-y OS=34%.”
Read Further.
Source: Fadi Haddad/X
Fadi Haddad is an Assistant Professor in the Department of Leukemia at the Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center in Houston, TX. He serves as a member of the Leading Clinical Research Faculty Learning Series. His postgraduate training includes a clinical fellowship in leukemia at MD Anderson Cancer Center and a clinical residency in hematology/oncology at Hotel Dieu de France Hospital in Beirut.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
May 31, 2025, 07:54
May 31, 2025, 07:39
May 31, 2025, 07:32
May 31, 2025, 07:20
May 31, 2025, 07:14
May 31, 2025, 06:50